alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › clinical-implications

clinical-implications

2 studies tagged clinical-implications, dated 2017-11-01 to 2023-07-31. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Prevalence and Clinical Implications of a β-Amyloid-Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease 2023-07-31
  2. REM Sleep Behavior Disorder: Diagnosis, Clinical Implications, and Future Directions 2017-11-01

Studies

2 studies carry this tag.

Date range

2017 to 2023

Top journals

  • JAMA neurology 1
  • Mayo Clinic proceedings 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Prevalence and Clinical Implications of a β-Amyloid-Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease

    ✓ Peer-reviewed alzhub usefulness score 76 out of 100. JAMA neurology 2023-07-31 Biomarkers

    Longitudinally, no significant differences in rates of worsening were observed between A-T+ and A-T- profiles for cognition or imaging biomarkers.

  2. REM Sleep Behavior Disorder: Diagnosis, Clinical Implications, and Future Directions

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Mayo Clinic proceedings 2017-11-01 Brain scans and imaging

    Rapid eye movement sleep behavior disorder (RBD) is diagnosed by a clinical history of dream enactment accompanied by polysomnographic rapid eye movement sleep atonia loss (rapid eye movement sleep without atonia).

All topic tags with their study counts